3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Completed
2
Active not recruiting
2
Unknown
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Other hematologic neoplasm
1
Conditions
Colorectal Neoplasms
28
Stomach Neoplasms
21
Pancreatic Neoplasms
14
Colonic Neoplasms
14
Rectal Neoplasms
9
Esophageal Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
7
Adenocarcinoma Of Esophagus
7
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Cholangiocarcinoma
4
Adenocarcinoma
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Unresectable Colorectal Cancer
1
Triple Negative Breast Neoplasms
1
Spinocerebellar Degenerations
1
Solid Cancer
1
Skin Neoplasms
1
Recurrence
1
Interventions
Rituximab
25
Lenalidomide
20
Cyclophosphamide
18
obinutuzumab
8
Vincristine
8
Doxorubicin
8
Prednisone
7
Bendamustine Hydrochloride
7
tazemetostat
6
ibrutinib
6
Biopsy
6
venetoclax
5
pembrolizumab
5
fludarabine
5
Specimen Handling
5
CT-P10
5
fludarabine phosphate
4
R-CHOP protocol
4
Peripheral Blood Stem Cell Transplantation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Prednisolone
3
Etoposide
3
tocilizumab
2
copanlisib
2
axicabtagene ciloleucel
2
atezolizumab
2
acalabrutinib
2
abexinostat
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphoma, Follicular
×
Oxaliplatin
×
Clear all
NCT04542824
2026-06-02
EPCOREâ„¢ NHL-3
Genmab
Phase 1/2
Active not recruiting
78 enrolled
NCT04663347
2026-06-02
EPCOREâ„¢ NHL-2
Genmab
Phase 1/2
Active not recruiting
543 enrolled